Virtual Medical Academy

Overview

This session will provide a comprehensive overview of the evolving role of incretin-based therapies in the management of obesity, type 2 diabetes, and obstructive sleep apnea (OSA). Participants will explore the latest clinical evidence, practical treatment approaches, and real-world case discussions focused on improving patient outcomes through integrated and multidisciplinary care. The session will also address current challenges, and strategies for incorporating these therapies effectively into daily clinical practice.

This Activity for

Resident / Fellow
Physician
Clinical Pharmacy

What I will learn?

- Recognize the latest evidence and best practices in the management of chronic weight management (CWM), obstructive sleep apnea (OSA) in patients with obesity, and type 2 diabetes using incretin-based therapies.
- Explain practical strategies for integrating incretin-based therapies into clinical practice to enhance patient outcomes and long-term disease management.
- Discuss complex cases, real-world experiences, and current clinical challenges to promote collaborative learning and multidisciplinary patient care.